TransMedics Group
TMDX

TransMedics Group (TMDX) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
Piper SandlerMaintainedOverweight$100.00 from $120.00Aug 5, 2026
UBSMaintainedNeutral$77.00 from $80.00Aug 5, 2026
NeedhamMaintainedBuy$106.00 from $142.00Aug 3, 2026
UBSInitiated CoverageNeutral$80.00Jul 28, 2026
Evercore ISI GroupMaintainedOutperform$90.00 from $100.00Jul 6, 2026
TD CowenMaintainedBuy$120.00Jul 1, 2026
Canaccord GenuityMaintainedBuy$124.00Jun 30, 2026
StifelMaintainedHold$80.00 from $75.00Jun 18, 2026
StifelMaintainedHold$75.00 from $85.00May 26, 2026
NeedhamMaintainedBuy$142.00 from $174.00May 6, 2026
Piper SandlerMaintainedOverweight$120.00 from $160.00May 6, 2026
StifelMaintainedHold$85.00 from $130.00May 6, 2026
TD CowenMaintainedBuy$120.00 from $190.00May 6, 2026
Canaccord GenuityMaintainedBuy$124.00 from $152.00May 6, 2026
Evercore ISI GroupMaintainedOutperform$118.00 from $170.00Apr 6, 2026
StifelMaintainedHold$130.00 from $115.00Mar 9, 2026
NeedhamMaintainedBuy$174.00 from $166.00Feb 25, 2026
Evercore ISI GroupMaintainedOutperform$170.00 from $155.00Feb 25, 2026
Piper SandlerMaintainedOverweight$160.00 from $140.00Feb 25, 2026
JP MorganMaintainedNeutral$149.00 from $114.00Feb 25, 2026

Frequently asked questions

  • What is the latest analyst rating on TMDX?

    On Aug 5, 2026, Piper Sandler maintained TransMedics Group at Overweight with a price target of $100.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.